Vikas_Narayana

A Bright Sun for Sun Pharma : Target Rs1000 ?

Pembelian
NSE:SUNPHARMA   SUN PHARMACEUTICAL
SUNPHARMA is a constant and stable wealth generator.
The regular dividend of Rs2.5/share been given every September each year shows its stable income.

The rise in pharma will also push this scrip and I see a target of Rs1000 in coming weeks for Sun Pharma.



Every idea in this profile is for educational and predictive accuracy log purpose directed to personal use.
I don't recommend trading whatsoever.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.